vTv Therapeutics (VTVT) Shares Outstanding (2015 - 2026)

vTv Therapeutics (VTVT) has 11 years of Shares Outstanding (Entity) data on file, last reported at $622251.0 in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Entity) fell 61.82% year-over-year to $622251.0; the trailing twelve-month figure through Mar 2026 stood at $622251.0 (down 61.82% YoY), and the FY2025 full-year result was $6.3 million, up 366.23% from the prior year.
• Shares Outstanding (Entity) declined to $622251.0 in Q1 2026, from $6.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $6.3 million in Q4 2025 to a low of $622251.0 in Q1 2026.
• A 5-year average of $1.7 million and a median of $901566.0 in 2024 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) soared 369.23% in 2025 and plunged 61.82% in 2026, its largest moves.
• Tracing VTVT's Shares Outstanding (Entity) over 5 years: stood at $866308.0 in 2022, then rose by 4.25% to $903141.0 in 2023, then surged by 49.87% to $1.4 million in 2024, then surged by 366.23% to $6.3 million in 2025, then tumbled by 90.14% to $622251.0 in 2026.
• Business Quant data shows VTVT's Shares Outstanding (Entity) at $622251.0 in Q1 2026, $6.3 million in Q4 2025, and $6.3 million in Q3 2025.